Clinical Trials Logo
  1. Home
  2. Liver Cirrhosis
  3. NCT04668664
  4. Details
NCT04668664 Clinical Trial

Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements

Liver Cirrhosis Clinical Trial

Official title:
PORTAL: Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04668664
Other study ID # 16-03
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 5, 2021
Est. completion date June 13, 2022

Study information
Verified date June 2022
Source Cook Group Incorporated
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of the study is to collect and report technical success of direct endoscopic ultrasound guided hepatic and portal vein pressure measurement obtained with EchoTip® Insight™ in patients with cirrhosis who are referred for an EGD and/or EUS.

Recruitment information / eligibility
Status Completed
Enrollment 70
Est. completion date June 13, 2022
Est. primary completion date June 13, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: Patient who has been referred for an EGD and/or EUS procedure and direct pressure measurement. General Exclusion Criteria: - Patient is pregnant, breast-feeding, or planning to become pregnant during the course of the study. - Patient is unwilling or unable to sign and date the informed consent. - Patient is unwilling or unable to comply with the follow-up study schedule. - Patient for whom endoscopic procedures are contraindicated

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• EchoTip® Insight™ Portosystemic Pressure Gradient Measurement System (EchoTip® Insight™)
Measuring the portal pressure gradient in patients with cirrhosis who are referred for an esophagogastroduodenoscopy (EGD) and/or endoscopic ultrasound (EUS).

Locations
Country Name City State
Australia Royal Brisbane Women's Hospital Herston
Hong Kong Prince of Wales Hospital/Chinese University of Hong Kong Sha Tin
United States Brigham & Women's Hospital Boston Massachusetts
United States University of Virginia Medical Center Charlottesville Virginia
United States The University of Kansas Health System Kansas City Kansas
United States New York-Presbyterian Hospital/Weill Cornell University Medical Center New York New York
United States University of California, Irvine Orange California

Sponsors (1)
Lead Sponsor Collaborator
Cook Research Incorporated

Countries where clinical trial is conducted

United States,  Australia,  Hong Kong, 

Outcome
Type Measure Description Time frame Safety issue
Primary Portal Pressure Gradient Measurement Number of participants that the Portal Pressure Gradient measurement was obtainable. once the measurement is calculated (approximately 1 hour)
See also
  Status Clinical Trial Phase
Recruiting NCT04533932 - Endosonographic Shear Wave Elastography for Liver Stiffness
Not yet recruiting NCT06031740 - A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal Hemorrhoids N/A
Not yet recruiting NCT06026267 - Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis N/A
Not yet recruiting NCT06076330 - Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension N/A
Enrolling by invitation NCT05055713 - A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism N/A
Recruiting NCT04578301 - Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
Not yet recruiting NCT05515861 - Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices N/A
Not yet recruiting NCT05120557 - Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH N/A
Not yet recruiting NCT03623360 - Functional MRI to Determine Severity of Cirrhosis
Not yet recruiting NCT02710227 - Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic Cirrhosis N/A
Completed NCT02917408 - Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Active, not recruiting NCT02551250 - Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis
Recruiting NCT02239991 - Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant N/A
Enrolling by invitation NCT02256514 - Open Label Trial of Immunotherapy for Advanced Liver Cancer Phase 2
Terminated NCT02311985 - Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial N/A
Terminated NCT01937130 - Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF Phase 2
Recruiting NCT01618890 - Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding Phase 3
Recruiting NCT01724697 - Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis Phase 1/Phase 2
Recruiting NCT01728688 - Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis Phase 1/Phase 2
Recruiting NCT01728727 - Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis Phase 1/Phase 2